Co-Authors
This is a "connection" page, showing publications co-authored by Giovanni Di Perri and Mattia Trunfio.
Connection Strength
2.361
-
Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases. Lancet Infect Dis. 2021 07; 21(7):914-915.
Score: 0.940
-
On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases. Front Microbiol. 2021; 12:646679.
Score: 0.234
-
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients. Viruses. 2021 02 11; 13(2).
Score: 0.232
-
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection. Thromb Res. 2020 12; 196:432-434.
Score: 0.227
-
Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy. Emerg Infect Dis. 2021 Jan; 27(1).
Score: 0.227
-
Co-infection with other respiratory pathogens in COVID-19 patients. Clin Microbiol Infect. 2021 Feb; 27(2):297-298.
Score: 0.225
-
Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity. Antivir Ther. 2020; 25(6):327-333.
Score: 0.215
-
Seroprevalence of SARS-CoV-2 Among Workers in Northern Italy. Ann Work Expo Health. 2022 02 18; 66(2):224-232.
Score: 0.062